Stocktoria
Nurix Therapeutics, Inc. NRIX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-07-24
Nurix Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,820,015 | $142.3M | 6.7% |
| ARK Investment Management LLC | 1,721,135 | $26.7M | 1.69% |
| CITADEL ADVISORS LLC | 1,380,300 | $21.4M | 1.36% |
| MILLENNIUM MANAGEMENT LLC | 546,297 | $8.5M | 0.54% |
| Point72 Asset Management, L.P. | 449,106 | $7.0M | 0.44% |
| D. E. Shaw & Co., Inc. | 344,203 | $5.3M | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 118,000 | $1.8M | 0.12% |
| AQR CAPITAL MANAGEMENT LLC | 16,406 | $254,294 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-11-30. Facts plus Stocktoria's own computed scores — not investment advice.